Alterations in self-reported sensory gating and interoception in individuals frequently using cannabis

References

• Research, & Trend Analysis Branch, U. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2022. (Booklet 2). Global Overview of Drug Demand and Drug Supply, Issue. 2022. https://www.unodc.org/res/wdr2022/MS/WDR22_Booklet_2.pdf.
   Google Scholar
• Substance, A., & Mental Health Services, A. Substance abuse and mental health services administration results from the 2013 national survey on drug use and health: summary of national findings. 2014. https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf.
   Google Scholar
• Trick L, Butler K, Bourgault Z, Vandervoort J, Le Foll B. Implementation and preliminary evaluation of a 12-week cognitive behavioural and motivational enhancement group therapy for cannabis use disorder. Subst Abuse. 2023;17:11782218231205840. doi:10.1177/11782218231205840.
   Web of Science ®Google Scholar
• Adams ZW, Marriott BR, Hulvershorn LA, Hinckley JD. Treatment of adolescent cannabis use disorders. Psychiatr Clin North Am. 2023;46:775–788. doi:10.1016/j.psc.2023.03.004.
   PubMed Web of Science ®Google Scholar
• Stephens RS, Walker R, DeMarce J, Lozano BE, Rowland J, Walker D, Roffman RA. Treating cannabis use disorder: exploring a treatment as needed model with 34-month follow-up. J Subst Abuse Treat. 2020;117:108088. doi:10.1016/j.jsat.2020.108088.
   PubMed Web of Science ®Google Scholar
• Burns DH, Van Laere K, Sanabria-Bohórquez S, Hamill TG, Bormans G, Eng W-S, Gibson R, Ryan C, Connolly B, Patel S, et al. [18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor. Proc Natl Acad Sci. 2007;104:9800–05. doi:10.1073/pnas.0703472104.
   PubMed Web of Science ®Google Scholar
• Scott JC, Slomiak ST, Jones JD, Rosen AFG, Moore TM, Gur RC. Association of cannabis with cognitive functioning in adolescents and young adults: a systematic review and meta-analysis. JAMA Psychiarty. 2018;75:585. doi:10.1001/jamapsychiatry.2018.0335.
   PubMed Web of Science ®Google Scholar
• O’Donnell BF, Skosnik PD, Hetrick WP, Fridberg DJ. Decision making and impulsivity in young adult cannabis users. Front Psychol. 2021;12:679904. doi:10.3389/fpsyg.2021.679904.
   PubMed Web of Science ®Google Scholar
• Raymond DR, Paneto A, Yoder KK, O’Donnell BF, Brown JW, Hetrick WP, Newman SD. Does chronic cannabis use impact risky decision-making: an examination of fMRI activation and effective connectivity? Front Psychiatry. 2020;11:599256. doi:10.3389/fpsyt.2020.599256.
   PubMed Web of Science ®Google Scholar
• Solowij N, Michie PT. Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci. 2007;32:30–52. https://pubmed.ncbi.nlm.nih.gov/17245472; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1764544/.
   PubMed Web of Science ®Google Scholar
• Fridberg DJ, Vollmer JM, O’Donnell BF, Skosnik PD. Cannabis users differ from non-users on measures of personality and schizotypy. Psychiatry Res. 2011;186:46–52. doi:10.1016/j.psychres.2010.07.035.
   PubMed Web of Science ®Google Scholar
• Muro i Rodríguez A. Age, sex and personality in early cannabis use. European Psychiatry. 2015;30:469–73. doi:10.1016/j.eurpsy.2015.02.008.
   PubMed Web of Science ®Google Scholar
• Skosnik PD, Spatz-Glenn L, Park S. Cannabis use is associated with schizotypy and attentional disinhibition. Schizophr Res. 2001;48:83–92. doi:10.1016/S0920-9964(00)00132-8.
   PubMed Web of Science ®Google Scholar
• Vaissiere J, Thorp JG, Ong J-S, Ortega-Alonso A, Derks EM. Exploring phenotypic and genetic overlap between cannabis use and schizotypy. Twin Res Hum Genet. 2020;23:221–227. doi:10.1017/thg.2020.68.
   PubMed Web of Science ®Google Scholar
• Micoulaud-Franchi J-A, Lopez R, Cermolacce M, Vaillant F, Péri P, Boyer L, Richieri R, Bioulac S, Sagaspe P, Philip P, et al. Sensory gating capacity and attentional function in adults with ADHD: a preliminary neurophysiological and neuropsychological study. J Atten Disord. 2019;23:1199–1209.
   PubMed Web of Science ®Google Scholar
• Oliveira I, Vaz Garrido M, Carvalho H, Figueira Bernardes S. Sensing the body matters: profiles of interoceptive sensibility in chronic pain adjustment. Pain. 2023;165:412–22. doi:10.1097/j.pain.0000000000003032.
   PubMed Web of Science ®Google Scholar
• Reader AT, Salvato G. Investigating the relationship between self-reported interoceptive experience and risk propensity. Cogn Emot. 2023;38:1–15. doi:10.1080/02699931.2023.2279160.
   Web of Science ®Google Scholar
• Boutros NN, Belger A. Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating. Biol Psychiatry. 1999;45:917–922. doi:10.1016/S0006-3223(98)00253-4.
   PubMed Web of Science ®Google Scholar
• Grunwald T, Boutros NN, Pezer N, von Oertzen J, Fernández G, Schaller C, Elger CE. Neuronal substrates of sensory gating within the human brain. Biol Psychiatry. 2003;53:511–519. doi:10.1016/S0006-3223(02)01673-6.
   PubMed Web of Science ®Google Scholar
• Broyd SJ, Greenwood L-M, Croft RJ, Dalecki A, Todd J, Michie PT, Johnstone SJ, Solowij N. Chronic effects of cannabis on sensory gating. Int J Psychophysiol. 2013;89:381–389. doi:10.1016/j.ijpsycho.2013.04.015.
   PubMed Web of Science ®Google Scholar
• Edwards CR, Skosnik PD, Steinmetz AB, O’Donnell BF, Hetrick WP. Sensory gating impairments in heavy cannabis users are associated with altered neural oscillations. Behav Neurosci. 2009;123:894–904. doi:10.1037/a0016328.
   PubMed Web of Science ®Google Scholar
• Patrick G, Struve FA. Reduction of auditory P50 gating response in marihuana users: further supporting data. Clin Electroencephalogr. 2000;31:88–93. doi:10.1177/155005940003100207.
   PubMedGoogle Scholar
• Rentzsch J, Penzhorn A, Kernbichler K, Plockl D, Gomezcarrillodecastro A, Gallinat J, Jockersscherubl M. Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls. Exp Neurol. 2007;205:241–249. doi:10.1016/j.expneurol.2007.02.004.
   PubMed Web of Science ®Google Scholar
• Hetrick WP, Erickson MA, Smith DA. Phenomenological dimensions of sensory gating. Schizophr Bull. 2012;38:178–191. doi:10.1093/schbul/sbq054.
   PubMed Web of Science ®Google Scholar
• Kisley MA, Noecker TL, Guinther PM. Comparison of sensory gating to mismatch negativity and self-reported perceptual phenomena in healthy adults. Psychophysiology. 2004;41:604–612. doi:10.1111/j.1469-8986.2004.00191.x.
   PubMed Web of Science ®Google Scholar
• Micoulaud-Franchi J-A, Hetrick WP, Aramaki M, Bolbecker A, Boyer L, Ystad S, Kronland-Martinet R, Richieri R, Faget C, Faugere M, et al. Do schizophrenia patients with low P50-suppression report more perceptual anomalies with the sensory gating inventory? Schizophr Res. 2014;157:157–162.
   PubMed Web of Science ®Google Scholar
• Khalsa SS, Adolphs R, Cameron OG, Critchley HD, Davenport PW, Feinstein JS, Feusner JD, Garfinkel SN, Lane RD, Mehling WE, et al. Interoception and mental health: a roadmap. Biol Psychiatry: Cognit Neurosci Neuroimaging. 2018;3:501–13. doi:10.1016/j.bpsc.2017.12.004.
   PubMedGoogle Scholar
• Craig AD. Significance of the insula for the evolution of human awareness of feelings from the body. Ann N Y Acad Sci. 2011;1225:72–82. doi:10.1111/j.1749-6632.2011.05990.x.
   PubMed Web of Science ®Google Scholar
• Naqvi NH, Bechara A. The hidden island of addiction: the insula. Trends Neurosci. 2009;32:56–67. doi:10.1016/j.tins.2008.09.009.
   PubMed Web of Science ®Google Scholar
• Verdejo-Garcia A, Clark L, Dunn BD. The role of interoception in addiction: a critical review. Neurosci Biobehav Rev. 2012;36:1857–1869. doi:10.1016/j.neubiorev.2012.05.007.
   PubMed Web of Science ®Google Scholar
• Paulus MP, Stewart JL. Interoception and drug addiction. Neuropharmacology. 2014;76:342–350. doi:10.1016/j.neuropharm.2013.07.002.
   PubMed Web of Science ®Google Scholar
• Droutman V, Read SJ, Bechara A. Revisiting the role of the insula in addiction. Trends Cogn Sci. 2015;19:414–420. doi:10.1016/j.tics.2015.05.005.
   PubMed Web of Science ®Google Scholar
• Naqvi NH, Bechara A. The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making. Brain Struct Funct. 2010;214:435–450. doi:10.1007/s00429-010-0268-7.
   PubMed Web of Science ®Google Scholar
• Stewart JL, Juavinett AL, May AC, Davenport PW, Paulus MP. Do you feel alright? Attenuated neural processing of aversive interoceptive stimuli in current stimulant users: Interoceptive processing in stimulant users. Psychophysiology. 2015;52:249–262. doi:10.1111/psyp.12303.
   PubMed Web of Science ®Google Scholar
• Filbey FM, Schacht JP, Myers US, Chavez RS, Hutchison KE. Marijuana craving in the brain. Proc Natl Acad Sci. 2009;106:13016–21. doi:10.1073/pnas.0903863106.
   PubMed Web of Science ®Google Scholar
• Hester R, Nestor L, Garavan H. Impaired error awareness and anterior cingulate cortex hypoactivity in chronic cannabis users. Neuropsychopharmacology. 2009;34:2450–2458. doi:10.1038/npp.2009.67.
   PubMed Web of Science ®Google Scholar
• Wetherill RR, Childress AR, Jagannathan K, Bender J, Young KA, Suh JJ, O’Brien CP, Franklin TR. Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals. Psychopharmacology. 2014;231:1397–1407. doi:10.1007/s00213-013-3342-z.
   PubMed Web of Science ®Google Scholar
• Sönmez MB, Kahyacı Kılıç E, Ateş Çöl I, Görgülü Y, Köse Çınar R. Decreased interoceptive awareness in patients with substance use disorders. J Subst Use. 2017;22:60–65. doi:10.3109/14659891.2016.1143048.
   Web of Science ®Google Scholar
• Mehling WE, Price C, Daubenmier JJ, Acree M, Bartmess E, Stewart A, Tsakiris M. The multidimensional assessment of interoceptive awareness (MAIA). PloS One. 2012;7:e48230. doi:10.1371/journal.pone.0048230.
   PubMed Web of Science ®Google Scholar
• Mehling WE, Acree M, Stewart A, Silas J, Jones A, Costantini M. The multidimensional assessment of interoceptive awareness, version 2 (MAIA-2). PloS One. 2018;13:e0208034. doi:10.1371/journal.pone.0208034.
   PubMed Web of Science ®Google Scholar
• Baranauskas M, Grabauskaitė A, Griškova-Bulanova I. Brain responses and self-reported indices of interoception: heartbeat evoked potentials are inversely associated with worrying about body sensations. Physiol Behav. 2017;180:1–7. doi:10.1016/j.physbeh.2017.07.032.
   PubMed Web of Science ®Google Scholar
• Stern ER, Grimaldi SJ, Muratore A, Murrough J, Leibu E, Fleysher L, Goodman WK, Burdick KE. Neural correlates of interoception: effects of interoceptive focus and relationship to dimensional measures of body awareness. Hum Brain Mapp. 2017;38:6068–6082. doi:10.1002/hbm.23811.
   PubMed Web of Science ®Google Scholar
• May AC, Jacobus J, Stewart JL, Simmons AN, Paulus MP, Tapert SF. Do adolescents use substances to relieve uncomfortable sensations? A preliminary examination of negative reinforcement among adolescent cannabis and alcohol users. Brain Sci. 2020;10:214. doi:10.3390/brainsci10040214.
   PubMed Web of Science ®Google Scholar
• Sara Julsrud H. Depression as a mediator of interoceptive sensibility and adolescent cannabis use frequency. Northwest University; 2020. https://archives.northwestu.edu/handle/nu/57383.
   Google Scholar
• Buckner JD, Zvolensky MJ, Crosby RD, Wonderlich SA, Ecker AH, Richter A. Antecedents and consequences of cannabis use among racially diverse cannabis users: an analysis from ecological momentary assessment. Drug Alcohol Depen. 2015;147:20–25. doi:10.1016/j.drugalcdep.2014.12.022.
   PubMed Web of Science ®Google Scholar
• Chapman LJ, Chapman JP, Raulin ML. Scales for physical and social anhedonia. J Abnorm Psychol. 1976;85:374–382. doi:10.1037/0021-843X.85.4.374.
   PubMed Web of Science ®Google Scholar
• Krueger RF, Derringer J, Markon KE, Watson D, Skodol AE. Initial construction of a maladaptive personality trait model and inventory for DSM-5. Psychol Med. 2012;42:1879–1890. doi:10.1017/S0033291711002674.
   PubMed Web of Science ®Google Scholar
• First MB, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for DSM-5—research version (SCID-5 for DSM-5, research version; SCID-5-RV). American Psychiatric Association; 2015.
   Google Scholar
• Micoulaud-Franchi J-A, Hetrick WP, Boyer L, Bolbecker A, Aramaki M, Ystad S, Richieri R, El-Kaim A, Faget C, Faugere M, et al. Validation of the French sensory gating inventory: a confirmatory factor analysis. Psychiatry Res. 2014;220:1106–1112.
   PubMed Web of Science ®Google Scholar
• Mohebbi M, Mahmoudian S, Motevalian SA, Janani L, Farhadi M, Daneshi A. Developing Persian version of Sensory Gating Inventory ‎‎(SGI): validity and reliability‎. Basic And Clinical Neuroscience Journal. 2019. doi:10.32598/bcn.9.10.360.
   Google Scholar
• Willem C, Gandolphe M-C, Nandrino J-L, Grynberg D. French translation and validation of the Multidimensional Assessment of Interoceptive Awareness (MAIA-FR). Can J Behav Sci/Revue canadienne des sciences du comportement. 2021;54:234–40. doi:10.1037/cbs0000271.
   Web of Science ®Google Scholar
• Özpinar S, Dunder E, DemiR Y, Akyol M. Multidimensional assessment of ınteroceptive awareness (MAIA 2): psychometric properties of the Turkish version. J Health Sci Med Res. 2021;4:132–36. doi:10.32322/jhsm.836361.
   Google Scholar
• Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, Sellman JD. An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R)☆. Drug Alcohol Depen. 2010;110:137–143. doi:10.1016/j.drugalcdep.2010.02.017.
   PubMed Web of Science ®Google Scholar
• Schultz NR, Bassett DT, Messina BG, Correia CJ. Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students. Addict Behav. 2019;95:11–15. doi:10.1016/j.addbeh.2019.02.016.
   PubMed Web of Science ®Google Scholar
• Risi M, Sokolovsky A, White H, Jackson K. Factor structure of the Cannabis Use Disorders Identification Test Revised (CUDIT-R) for men and women. Cannabis. 2020;3:148–156. doi:10.26828/cannabis.2020.02.002.
   PubMedGoogle Scholar
• Luquiens A, Berger‐Viergat A, Larrieu A, Artigaud L, Fener C, Adamson S, Laprévote V, Rolland B. Validation of the French version of the cannabis use disorder identification test—revised and comparison with the cannabis abuse screening test for screening cannabis use disorder in a psychiatric sample. Drug Alcohol Rev. 2021;40:1334–1339. doi:10.1111/dar.13298.
   PubMed Web of Science ®Google Scholar
• Sobell LC, Sobell MB, Buchan G. Timeline followback method (drugs, cigarettes, and marijuana). 1996.
   Google Scholar
• Brown RA, Burgess ES, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline follow-back interview. Psychol Addict Behav. 1998;12:101–112. doi:10.1037/0893-164X.12.2.101.
   Web of Science ®Google Scholar
• Hjorthøj CR, Hjorthøj AR, Nordentoft M. Validity of timeline follow-back for self-reported use of cannabis and other illicit substances — systematic review and meta-analysis. Addict Behav. 2012;37:225–233. doi:10.1016/j.addbeh.2011.11.025.
   PubMed Web of Science ®Google Scholar
• Robinson SM, Sobell LC, Sobell MB, Leo GI. Reliability of the timeline followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav. 2014;28:154–162. doi:10.1037/a0030992.
   PubMed Web of Science ®Google Scholar
• Team RC.R: a language and environment for statistical computing. In R Foundation for Statistical Computing; 2022. https://www.R-project.org/.
   Google Scholar
• Jari Oksanen GLS, Guillaume Blanchet F, Kindt R, Legendre P, Minchin PR, O’Hara RB, Peter Solymos MHHS, Szoecs E, Wagner H, Barbour M, et al. Vegan: community ecology package. Version R Package Version 2.6-4. 2022. https://CRAN.R-project.org/package=vegan.
   Google Scholar
• Torchiano M. Effsize: Efficient effect size computation. Version R Package Version 0.8.1. 2020. https://CRAN.R-project.org/package=effsize.
   Google Scholar
• Hecimovic K, Barrett SP, Darredeau C, Stewart SH. Cannabis use motives and personality risk factors. Addict Behav. 2014;39:729–732. doi:10.1016/j.addbeh.2013.11.025.
   PubMed Web of Science ®Google Scholar
• Chabrol H, Melioli T, Goutaudier N. Association between personality disorders traits and problematic cannabis use in adolescents. Subst Use Misuse. 2015;50:552–556. doi:10.3109/10826084.2014.984851.
   PubMed Web of Science ®Google Scholar
• Smith MJ, Cobia DJ, Reilly JL, Gilman JM, Roberts AG, Alpert KI, Wang L, Breiter HC, Csernansky JG. Cannabis-related episodic memory deficits and hippocampal morphological differences in healthy individuals and schizophrenia subjects: CANNABIS and EPISODIC MEMORY. Hippocampus. 2015;25:1042–1051. doi:10.1002/hipo.22427.
   PubMed Web of Science ®Google Scholar
• Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59:1337–1343. doi:10.1212/01.WNL.0000031422.66442.49.
   PubMed Web of Science ®Google Scholar
• Brabete AC, Greaves L, Hemsing N, Stinson J. Sex- and gender-based analysis in cannabis treatment outcomes: a systematic review. Int J Environ Res Public Health. 2020;17:872. doi:10.3390/ijerph17030872.
   PubMed Web of Science ®Google Scholar
• Lopez-Quintero C, Cobos JPDL, Hasin DS, Okuda M, Wang S, Grant BF, Blanco C. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depen. 2011;115:120–30. doi:10.1016/j.drugalcdep.2010.11.004.
   PubMed Web of Science ®Google Scholar
• Zeiger JS, Silvers WS, Fleegler EM, Zeiger RS. Age related differences in cannabis use and subjective effects in a large population-based survey of adult athletes. J Cannabis Res. 2019;1:7. doi:10.1186/s42238-019-0006-9.
   PubMedGoogle Scholar